Status:

RECRUITING

Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study

Lead Sponsor:

Intermountain Health Care, Inc.

Collaborating Sponsors:

SomaLogic, Inc.

Conditions:

Health Behavior

Eligibility:

All Genders

40-80 years

Phase:

NA

Brief Summary

Feasibility Study Informed consent will be obtained using an IRB-approved form. The first 12 consenting patients will be placed in the planned assessment group for feasibility and will not be randomiz...

Eligibility Criteria

Inclusion

  • Male or female 40 - 80 years of age
  • Receiving care at Intermountain Medical Center
  • At higher than typical risk for cardiovascular events, as assessed by the Principal Investigator or his/her delegate (further defined in the protocol)
  • Currently not pregnant
  • Ability to understand and sign a written informed consent form which must be obtained prior to initiation of any study procedures
  • Willing and able to comply with any virtual or in-person follow-up visits, tests, and schedule of evaluations
  • Willing and able to undergo a blood draw for SomaSignal Tests
  • Willing and able to provide access to their electronic health records

Exclusion

  • Presence of Systemic Lupus Erythematosus
  • Inability to communicate appropriately
  • Participation in any other clinical trials involving investigational or marketed products within 30 days prior to entry in the study
  • Other conditions that in the opinion of the Principal Investigator and/or Co-Principal Investigators may increase risk to the participants and/or compromise the quality of the clinical trial
  • The Principal Investigator and/or Co-Principal Investigator determine(s) that the participant is not eligible for participation in this research study.

Key Trial Info

Start Date :

August 12 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 12 2025

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04836117

Start Date

August 12 2021

End Date

August 12 2025

Last Update

May 24 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Intermountain Medical Center

Salt Lake City, Utah, United States, 84107